Children submitted to fetoscopic in utero myelomeningocele repair using the SAFER (Skin-over-biocellulose for Anternatal FEtoscopic Repair) technique will evaluate at 30 months or more, regarding ambulation, neurodevelopment, urinary and fecal status.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Hydrocephalus treatment - shunt or ETV
Timeframe: 12 months corrected age or more
Ambulation
Timeframe: 30 months of cronological age or more
Neurodevelopmental test
Timeframe: 30 months of cronogical age or more